Riqas, ISO 13485 and Ukas accredited, is the largest global EQA scheme, designed to maintain and improve the quality of clinical testing
Randox International Quality Assessment Scheme (Riqas) provides a quick and easy assessment of your laboratory analytical performance.
With over 7500 participants, and an extensive range of programmes available, RIQAS guarantees confidence in your results.
The establishment of inter laboratory agreement ensures complete confidence in results for both the clinician and patient.
Participants are provided with bi-weekly or monthly reports which allow statistical comparison of analytical performance with other laboratories using the same methods and/or instruments.
Reports can be sent by fax, e-mail or via the internet using e-transfer improving turnaround time to only three days.
Graphical outputs including histograms, Levey-Jennings charts as well as unique target scoring charts are easy to understand and quickly identify unsatisfactory performance.
An independent advisory panel and Riqas support staff are on hand for additional support.
Riqas currently provides nine programmes covering clinical chemistry, therapeutic drugs, specific proteins, human urine, immunoassay, haematology, lipid, cardiac and Hb1Ac.
A total of six new programmes are due to start in January; coagulation, urinalysis, liquid cardiac, blood gas, maternal screening and urine toxicology.
Invest in this internationally recognised scheme now to improve the analytical quality of your laboratory and thus facilitate optimal patient care.
